-
Fox Chase earns radiopharmaceutical therapy honor
Philadelphia-based Fox Chase Cancer Center has been named a Comprehensive Radiopharmaceutical Therapy Center of Excellence by the Society of Nuclear Medicine & Molecular Imaging. Fox Chase is the first center in Philadelphia and one of three in Pennsylvania to receive the designation. -
Unplanned readmission rates of PPS-exempt cancer hospitals
Buffalo, N.Y.-based Roswell Park Comprehensive Cancer Center had the lowest 30-day unplanned readmission rate of cancer hospitals exempt from reporting to Medicare's Inpatient Prospective Payment System. -
States with highest, lowest breast cancer screening rates
The state of Wyoming had the lowest breast cancer screening rate in 2022 at 59.5% — nearly 20% lower than the state with the highest rate of 78.4%, Rhode Island. -
Nebraska cancer center launches prevention, control program
Omaha, Neb.-based University of Nebraska Medical Center's Fred & Pamela Buffett Cancer Center has launched a new cancer prevention and control program to address cancer risk factors and population disparities specific to Nebraska. -
Some experts voice concern over FDA's dense breast notification rule: NBC News
Effective Sept. 10, the FDA required healthcare facilities providing breast imaging services to notify patients of their breast density in mammography reports. Now, some experts are expressing concern over the new mandate, according to an Oct. 12 report from NBC News. -
NCI offers health systems a toolkit for cancer survivorship care
The National Cancer Institute has launched a toolkit as part of its National Standards for Cancer Survivorship Care initiative to help health systems develop and improve survivorship care programs. -
KU Cancer Center launches survivorship program
Kansas City-based University of Kansas Cancer Center has launched the Center for Survivorship and Patient-Oriented Research as part of an initiative to improve not only cancer survival rates, but cancer survivor quality of life. -
NYU Langone launches molecular oncology program, names leader
New York City-based NYU Langone has named Shridar Ganesan, MD, PhD, as director of the Perlmutter Cancer Center's new Center for Molecular Oncology. In collaboration with teams across NYU Langone, Dr. Ganesan will lead integration of genomic sequencing to personalize cancer care plans. -
MD Anderson joins global cancer initiative
Houston-based University of Texas MD Anderson Cancer Center has partnered with the Union for International Cancer Control to address breast and cervical cancer on a global scale. -
Cancer survival grows with ACA coverage: 4 study takeaways
Cancer survival among young adults has increased since the ACA's Dependent Care Expansion passed in 2010, allowing Americans to stay on their parents' health insurance plans until turning 26 years old, according to a study published Oct. 7 in Cancer. -
Cedars-Sinai joins Asian American cancer initiative
Los Angeles-based Cedars-Sinai is participating in the National Cancer Institute's first long-term national study of cancer among Asian Americans. Led by the University of California San Francisco, the study aims to learn why Asian Americans experience higher rates of cancer compared to other groups. -
Where MD Anderson, City of Hope leaders see progress
Advancements in immunotherapy and personalized medicine have pushed the oncology field forward, according to leaders from MD Anderson and City of Hope who shared their insights with Becker's. -
U of Iowa Health Care eyes cancer care business in $280M deal
Iowa City-based University of Iowa Health Care and Mission Cancer + Blood plan to partner in a $280 million deal to create a comprehensive cancer care network. -
US spent $99B on cancer drugs in 2023: 5 things to know
The U.S. spent $99 billion on both oral and clinician-administered cancer therapies in 2023, according to a report published in April by analytics firm IQVIA. As cancer drug prices continue to increase, spending is projected to grow. -
'Where did they go before?': Inside Essentia's rural cancer care strategy
Daniel Nikcevich, MD, saw a boat heading straight for him during a fishing trip in rural Minnesota. -
Mayo Clinic's $9M cancer center expansion: 4 things to know
Rochester, Minn.-based Mayo Clinic has broken ground on a $9 million cancer center expansion at its New Prague, Minn., medical campus. -
7 cancer drugs FDA approved in September
Along with the premarket approval of Siemens' 3D breast-imaging technology, the FDA approved seven oncology and hematology drugs in September. -
6 systems, cancer centers join supportive care consortium
Six U.S. health systems and cancer centers have joined the recently launched Together for Supportive Cancer Care consortium alongside more than 30 research institutions and advocacy groups with the aim to make supportive cancer care the standard of care. -
Immunologist joins Columbia from Memorial Sloan Kettering
Michel Sadelain, MD, PhD, a CAR-T therapy innovator and one of the world's top immunologists, has left New York City-based Memorial Sloan Kettering Cancer Center for two new roles at Columbia University Irving Medical Center, also in New York City. -
Breast cancer rates rise among young women, Asian Americans
From 2012 to 2021, breast cancer incidence has risen 1%, with steep increases among young women and Asian American/Pacific Islander women, according to the American Cancer Society.
Page 1 of 50